The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Development and Testing of Novel Contrast Agents for Diagnostic Imaging. Demand for diagnostic imaging in the Australian healthcare system is growing at over 5% per annum. To facilitate imaging, Australia imports radiographic contrast media costing in excess of $50 million every year. Existing iodine-based agents are not ideal for X-ray absorption in current CT scanners and also cause moderate to severe allergic reaction in around 5% of all patients, sometimes with fatal results. New radiograph ....Development and Testing of Novel Contrast Agents for Diagnostic Imaging. Demand for diagnostic imaging in the Australian healthcare system is growing at over 5% per annum. To facilitate imaging, Australia imports radiographic contrast media costing in excess of $50 million every year. Existing iodine-based agents are not ideal for X-ray absorption in current CT scanners and also cause moderate to severe allergic reaction in around 5% of all patients, sometimes with fatal results. New radiographic media, which give enhanced contrast and provide greater patient comfort and safety are essential. Even a small fraction of the international market would generate millions of dollars in income, support growth and expertise in Imaging Technologies, and provide new markets for Australian mining of rare earth and bismuth metals.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100109
Funder
Australian Research Council
Funding Amount
$530,000.00
Summary
Small molecule X-ray molecular structure elucidation facility. X-ray diffraction plays a key role in identification and molecular characterisation. X-ray techniques are the single most widely used analytical resource in structure determination and provide invaluable information for scientists working in the fields of synthesis, nanotechnology, polymer chemistry, and protein chemistry, amongst many others. The facility brings together a multidisciplinary team of scientists and provides state-of-t ....Small molecule X-ray molecular structure elucidation facility. X-ray diffraction plays a key role in identification and molecular characterisation. X-ray techniques are the single most widely used analytical resource in structure determination and provide invaluable information for scientists working in the fields of synthesis, nanotechnology, polymer chemistry, and protein chemistry, amongst many others. The facility brings together a multidisciplinary team of scientists and provides state-of-the-art research and training facilities for these techniques.Read moreRead less
Development of non-iodinated, non ionic, water-soluble metal based compounds for clinical administration as radiographic contrast media. Every year Australia spends more than $50 million on importing radiographic contrast media, in an international market worth more than $1 billion pa. Existing iodine based agents, which currently cause major adverse reactions in 1% of the population, could be replaced by new metal based imaging media which provide both enhanced contrast and greater patient safe ....Development of non-iodinated, non ionic, water-soluble metal based compounds for clinical administration as radiographic contrast media. Every year Australia spends more than $50 million on importing radiographic contrast media, in an international market worth more than $1 billion pa. Existing iodine based agents, which currently cause major adverse reactions in 1% of the population, could be replaced by new metal based imaging media which provide both enhanced contrast and greater patient safety and comfort. Even a small fraction of the international market would generate millions of dollars in overseas income from a range of potential sources, including licensing/royalties to export by a local start-up company, and expansion of rare earth mining in Australia.Read moreRead less